<DOC>
	<DOCNO>NCT00916097</DOCNO>
	<brief_summary>Primary Objective : To estimate overall response rate neo-adjuvant chemotherapy Docetaxel 75 mg/m2 combination Cisplatin 75 mg/m2 give 3 cycle , follow conventional radiotherapy UCNT . Secondary Objectives : To evaluate : - The radiological response chemotherapy radiotherapy - The pathological response chemotherapy cavum biopsy To estimate : - The duration overall response - The time progression ( T.T.P ) To analyze : - The overall survival - The safety profile</brief_summary>
	<brief_title>NPC Study : TAX + CIS Neoadjuvant Patients With Loco Regionally Advanced Undifferentiated Carcinoma Nasopharyngeal Type ( UCNT )</brief_title>
	<detailed_description />
	<mesh_term>Head Neck Neoplasms</mesh_term>
	<mesh_term>Carcinoma</mesh_term>
	<mesh_term>Docetaxel</mesh_term>
	<criteria>Inclusion criterion : Written witness oral informed consent prior begin specific protocol procedure &gt; Histologically proven undifferentiated carcinoma nasopharyngeal type ( UCNT stage IIIII OMS ) first diagnosis Staging disease : stage III , IV A , IV B ( UICC/AJCC , 1997 classification ) , T , N2 N3 UCNT , without metastasis Adenopathy &gt; 3 cm Patients require unidimensionally measurable disease RECIST method Performance status 1 karnofsky index 3 Previous therapy : Chemotherapy : none Radiation therapy : none Surgery : none Laboratory requirement Exclusion criterion : Prior chemotherapy / radiotherapy Metastatic disease ( M per UCCI/AJC classification ) Past current history neoplasm UCNT , except curatively treat non melanoma skin cancer situ carcinoma cervix cancer , curatively treat evidence disease previous 5 year Pregnant , lacting , patient childbearing potential must implement adequate contraceptive measure study participation Preexisting motor sensory neurotoxicity severity 3 grade 2 accord NCI criterion Others serious illness medical condition : 1.Congestive heart failure unstable angina pectoris even medically control 2.Previous history myocardial infraction within 1 year study entry 3.Uncontrolled hypertension high risk uncontrolled arrhythmias 4.Uncontrolled peptic ulcer , unstable diabetes mellitus susceptible contraindicate use corticoids 5.Concomitant treatment corticoid initiate &gt; 6 month prior study entry give dose methylprednisolone equivalent 3 20 mg 6.Definite contraindication use Corticoids 7.Concurrent treatment experimental drug 8.Participation another clinical investigational drug within 30 day prior study entry 9.Performance status = 2,3,4 karnofsky index &lt; 80 10 . History significant neurologic psychiatric disorder include psychotic disorder , dementia seizure would prohibit understanding give informed consent The information intend contain consideration relevant patient 's potential participation clinical trial .</criteria>
	<gender>All</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>June 2009</verification_date>
</DOC>